The aim to cure and relieve,
pays off our efforts and leads us into the future

Antoni Esteve i Subirana (1902-1979)

Esteve R&D Strategy

Strategy R&D

Our goal is to discover and develop new medicines that provide significant therapeutic value and improve the quality of life of patients.
R&D projects focus on providing patients and health professionals with solutions to therapeutic needs not properly met by the available treatments.

keep reading

PARTNERSHIP

Partnership has been at the center of ESTEVE's activities since our foundation in 1929. Through collaborative agreements and strategic alliances with companies worldwide, we have fostered innovation and achieved outstanding results and sustained growth.

keep reading
Esteve partnership

SUSTAINABILITY

We focus on economic balance and the social-environmental impact of our activities.

keep reading

Products and services

We cover the entire life cycle of the medicine: the development of the active ingredient, the creation of innovative medicines, and the production of generic drugs.

keep reading

Esteve in figures

804M€

net

sales

81M€

R&D

investments

586M€

internacional

sales

2636

people

employed

worldwide

Global presence

Our effort to foster internationalization is a major basis for growth and the future of our organization.

News

ESTEVE AWARDS THE BEST PATIENT CARE INITIATIVES

In the Medical Area the winner is a 360º Online Consultation Project developed in San Pedro de Alcántara (Malaga) that removes barriers between patients and healthcare providers.

In the P... read more

80% OF PATIENTS WITH COPD AND 50% OF PATIENTS WITH CHRONIC PAIN ARE POORLY TREATED

Primary care physicians are central to the approach of both conditions, which account for more than 60% of primary care consultations

The Syntesys symposium, organized by ESTEVE, help... read more

IN DIABETES, THE USE OF E-HEALTH IS MORE WIDESPREAD AMONG PATIENTS THAN AMONG PROFESSIONALS

Diabetes currently tops the list of apps available on health

According to experts, diabetes treatment should include the prescription of digital tools to supplement daily clinica... read more

This Website uses its own and third-party cookies to improve our services and analyse the user's browsing habits. If you continue browsing, we will consider you to have accepted their use. You can find more information by visiting our Cookies policy.